{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:51:31Z","timestamp":1782463891808,"version":"3.54.5"},"reference-count":165,"publisher":"SAGE Publications","issue":"1_suppl","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Toxicol"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:p>Alcohol Denat. is the generic term used by the cosmetics industry to describe denatured alcohol. Alcohol Denat. and various specially denatured (SD) alcohols are used as cosmetic ingredients in a wide variety of products. Many denaturants have been previously considered, on an individual basis, as cosmetic ingredients by the Cosmetic Ingredient Review (CIR) Expert Panel, whereas others, including Brucine and Brucine Sulfate, Denatonium Benzoate, and Quassin, have not previously been evaluated. Quassin is a bitter alkaloid obtained from the wood of Quassia amara. Quassin has been used as an insect antifeedant and insecticide and several studies demonstrate its effectiveness. At oral doses up to 1000 mg\/kg using rats, Quassin was not toxic in acute and short-term tests, but some reversible piloerection, decrease in motor activity, and a partial loss of righting reflex were found in mice at 500 mg\/kg. At 1000 mg\/kg given intraperitoneally (i.p.), all mice died within 24 h of receiving treatment. In a cytotoxicity test with brine shrimp, 1 mg\/ml of Quassin did not possess any cytotoxic or antiplasmodial activity. Quassin administered to rat Leydig cells in vitro at concentrations of 5\u201325 ng\/ml inhibited both the basal and luteinizing hormone (LH)-stimulated testosterone secretion in a dose-related fashion. Quassin at doses up to 2.0 g\/kg in drinking water using rats produced no significant effect on the body weights, but the mean weights of the testes, seminal vesicles, and epididymides were significantly reduced, and the weights of the anterior pituitary glands were significantly increased. The sperm counts and levels of LH, follicle-stimulating hormone (FSH), and testosterone were significantly lower in groups treated with Quassin. Brucine is a derivative of 2-hydroxystrychnine. Swiss-Webster mice given Brucine base, 30 ml\/kg, had an acute oral LD50 of 150 mg\/kg, with central nervous system depression followed by convulsions and seizures in some cases. In those animals that died, respiratory arrest was the cause. The acute i.p. LD50 for 15 ml\/kg of Brucine base was 62.0 mg\/kg, with central nervous system depression prior to the onset of convulsions, just as with oral Brucine. The acute intravenous (i.v.) LD50 was 12.0 mg\/kg. Brucine was nonmutagenic in an Ames assay at levels up to 6666 \u00ecg\/plate, with and without metabolic activation. In a repeat-insult patch test, for a hair care product containing 47% SD Alcohol 40 (95%), it was reported that Brucine Sulfate may be considered a nonprimary irritant and a nonprimary sensitizer. Three different sunscreen products (35% SD Alcohol 40-B, 72.4% SD Alcohol 40, and 74.5% SD Alcohol 40) did not show any signs of photoallergy in human subjects. Also, these three formulas did not exhibit any evidence of phototoxicity in humans. Denatonium Benzoate is a bitter substance detectable at a concentration of 10 ppb, discernibly bitter at 50 ppb, and unpleasantly bitter at 10 ppm. The distribution of topically applied lidocaine, a topical anesthetic chemically related to Denatonium Benzoate demonstrated that virtually no lidocaine appears in the plasma, suggesting that the larger Denatonium Benzoate molecule also would have little or no systemic exposure. Denatonium Benzoate (0.1%) did not show adverse effects in 10 rats in an acute inhalation toxicity test and 0.005% to 0.05% was nonirritating to ocular mucosa in 6 albino rabbits. The acute oral LD50 for the male rats was 640 mg\/kg and for females, 584 mg\/kg. The LD50 for the male rabbits was 508 mg\/kg and for the female rabbits, 640 mg\/kg. In two chronic toxicity studies, Denatonium Benzoate was administered (by gavage) at 1.6, 8, and 16 mg\/kg\/day, one using cynomologus monkeys and the other rats, resulted in no compound-related toxicity. The toxicity of SD Alcohols has also been tested, with implications for the particular denaturant used. An irritation test of 55.65% SD Alcohol 40-B denatured with Denatonium Benzoate using rabbits produced minimal effects. A spray formula containing 12% SD Alcohol 40-B was found to be nonirritating when evaluated for vaginal mucosal irritation in New Zealand white rabbits. Cosmetic formulations containing SD Alcohol 40-B (denatured with Denatonium Benzoate) were not sensitizers in repeated insult patch tests. A gel formula containing 29% SD Alcohol 40-B and a spray liquid containing 12% SD Alcohol 40-B did not induce photoallergy, dermal sensitization, or phototoxic response in human subjects. Although the absorption of ethanol (aka Alcohol for purposes of cosmetic ingredient labeling) occurs through skin, ethanol does not appear to affect the integrity of the skin barrier nor reach a very high systemic concentration following dermal exposure. Ethanol may be found in the bloodstream as a result of inhalation exposure and ingestion. Topically applied, ethanol can act as a penetration enhancer. Most of the systemic toxicity of ethanol appears to be associated with chronic abuse of alcohol. Although ethanol is denatured to make it unfit for consumption, there have been reports of intentional and unintentional consumption of products containing denatured alcohol. Ethanol is a reproductive and developmental toxicant. Ethanol is genotoxic in some test systems and it has been proposed that the genotoxic effects of ethanol are mediated via its metabolite, acetaldehyde. A brief summary is provided of the effects of chronic ingestion of alcohol including intoxication, liver damage, brain damage, and possible carcinogenicity. The CIR Expert Panel recognizes that certain ingredients in this group are reportedly used in a given product category, but the concentration of use is not available. Because dermal application or inhalation of cosmetic products containing these ingredients will not produce significant systemic exposure to ethanol, the CIR Expert Panel concluded that safety of the ingredients should be predicated on the safety of the denaturants used. The Panel considered that the adverse effects knownto be associated with Alcohol ingestion included in this safety assessment do not suggest a concern for Alcohol Denat. or SD Alcohols because of the presence of the denaturants, which are added for the express purpose of making the Alcohol unpotable. The CIR Expert Panel has previously conducted safety assessments of t-Butyl Alcohol, Diethyl Phthalate, Methyl Alcohol, Salicylic Acid, Sodium Salicylate, and Methyl Salicylate, in which each was affirmed safe or safe with qualifications. Given their use as denaturants are at low concentrations of use in Alcohol, the CIR Expert Panel determined that Alcohol Denat. denatured with t- Butyl Alcohol, Diethyl Phthalate, Methyl Alcohol, Salicylic Acid, Sodium Salicylate, and Methyl Salicylate is safe as used in cosmetic formulations with no qualifications. Likewise, because they are denatured with either t-Butyl Alcohol, Diethyl Phthalate, or Methyl Alcohol, SD Alcohols 3-A, 30, 39-B, 39-C, and 40-C all are considered safe as used. The Panel considered the available data for Denatonium Benzoate and SD Alcohol 40-B to be sufficient to support the safety of these ingredients in cosmetics. Denatonium Benzoate is sufficiently bitter that it is an effective denaturant at only 0.0006%. The Panel recognized that data on dermal penetration of Denatonium Benzoate were not available, but considered that the available data on lidocaine, a smaller structurally related chemical, indicates that dermal exposure does not result in measurable systemic exposure. The available data, however, were not sufficient to support the safety of Quassin, Brucine, and Brucine Sulfate, Alcohol Denat. denatured with those denaturants, or SD Alcohol 39 and SD Alcohol 40 (SD Alcohols denatured with Quassin, Brucine, and\/or Brucine Sulfate), and in order for the Expert Panel to reach a conclusion for these denaturants, additional data are needed.<\/jats:p>","DOI":"10.1080\/10915810802032388","type":"journal-article","created":{"date-parts":[[2008,6,21]],"date-time":"2008-06-21T08:29:33Z","timestamp":1214036973000},"page":"1-43","source":"Crossref","is-referenced-by-count":24,"title":["Final Report of the Safety Assessment of Alcohol Denat., Including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the Denaturants, Quassin, Brucine Sulfate\/Brucine, and Denatonium Benzoate1"],"prefix":"10.1177","volume":"27","member":"179","published-online":{"date-parts":[[2008,1,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1159\/000131466"},{"key":"atypb2","unstructured":"AMA Laboratories Inc. 1996. 100 Human Subject Repeat Insult Patch Test Skin Irritation\/Sensitization Evaluation. Unpublished data submitted by CTFA (13 pages)."},{"key":"atypb3","unstructured":"AMA Laboratories Inc. 1998a. 100 Human Subject Repeat Insult Patch Test Skin Irritation\/Sensitization Evaluation (Semi-Occlusive Patch). Unpublished data submitted by CTFA (14 pages)."},{"key":"atypb4","unstructured":"AMA Laboratories Inc. 1998b. 100 Human Subject Repeat Insult Patch Test Skin Irritation\/Sensitization Evaluation (Semi-Occlusive Patch). Unpublished data submitted by CTFA (10 pages)."},{"key":"atypb5","unstructured":"AMA Laboratories Inc. 1999a. 100 Human Subject Repeat Insult Patch Test Skin Irritation\/Sensitization Evaluation (Occlusive Patch). Unpublished data submitted by CTFA (14 pages)."},{"key":"atypb6","unstructured":"AMA Laboratories Inc. 1999b. 100 Human Subject Repeat Insult Patch Test Skin Irritation\/Sensitization Evaluation (Semi-Occlusive Patch). Unpublished data submitted by CTFA (10 pages)."},{"key":"atypb7","unstructured":"AMA Laboratories Inc. 2001. 100 Human Subject Repeat Insult Patch Test Skin Irritation\/Sensitization Evaluation (Occlusive Patch). Unpublished data submitted by CTFA (14 pages)."},{"key":"atypb8","unstructured":"Americhem Sales Corporation. 2000. Material safety datasheet for ethanol 95%. http:\/\/www.americhemsales.com\/MSDS%20HTMLS\/4932w3oy.htm. (accessed March 26, 2003)."},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1080\/109158101174381"},{"issue":"3","key":"atypb10","first-page":"1","volume":"22","year":"2003","journal-title":"Int. J. Toxicol."},{"issue":"2","key":"atypb11","first-page":"1","volume":"24","year":"2005","journal-title":"Int. J. Toxicol."},{"issue":"1","key":"atypb12","first-page":"34","volume":"24","year":"2005","journal-title":"Int. J. Toxicol."},{"key":"atypb13","first-page":"237","volume":"141","year":"1987","journal-title":"Am. J. Dis. Child."},{"key":"atypb14","unstructured":"Arena, J. M., and R. H. Drew, eds. 1986.Poisoning-Toxicology, symptoms, treatments, 5th ed., 273. Springfield, IL: Charles C. Thomas Publisher."},{"key":"atypb15","first-page":"25","volume":"85","year":"1977","journal-title":"Adv. Exp. Med. Biol."},{"key":"atypb16","first-page":"77","volume":"8","year":"1986","journal-title":"Neurobehav. Toxicol. Teratol."},{"key":"atypb17","first-page":"27","volume":"15","year":"1981","journal-title":"Tsitol. Genet."},{"key":"atypb18","first-page":"117","volume":"56","year":"1935","journal-title":"J. Pharmacol. Exp. Therapeu."},{"key":"atypb19","first-page":"683","volume":"37","year":"1976","journal-title":"Dis. Nerv. Syst."},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-0590(82)80063-8"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1980.tb05568.x"},{"key":"atypb22","first-page":"127","volume":"23","year":"1979","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"atypb23","first-page":"1073","volume":"21","year":"1997","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"atypb24","unstructured":"Budavari, S., ed. 1989.The Merck Index, 11th ed., 594. Rahway, NJ: Merck and Co."},{"key":"atypb25","unstructured":"Budavari, S., ed. 2001.The Merck Index, 13th ed., 243, 507, and 1437. White-house Station, NJ: Merck and Co."},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1987.48.388"},{"key":"atypb27","first-page":"1363","volume":"29","year":"1982","journal-title":"Am. J. Opthalmol."},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1097\/01.nrl.0000094941.96358.d1"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1021\/ja01284a046"},{"key":"atypb30","unstructured":"Code of Federal Regulations. 2002. From the U. S. Government Printing Office via GPO Access. Title 27, Volume 1, part 21, Subparts C and D. http:\/\/www.gpoaccess.gov\/ecfr\/ (accessed April 21, 2003)."},{"key":"atypb31","unstructured":"Committee of Revision of the United States Pharmacopeial Convention. 2004.\n                      The National Formulary\n                      , 22nd ed., 2858. Rockville, MD: United States Phar-macopeial Convention."},{"key":"atypb32","first-page":"1075","volume":"129","year":"1975","journal-title":"Am. J. Dis. Child."},{"key":"atypb33","unstructured":"Cosmetic, Toiletry, and Fragrance Association (CTFA). 1984a. Allergic Contact Sensitization Test-Deo Body Spray containing 98.2% Alcohol SD 40-B. Unpublished data submitted by CTFA (7 pages)."},{"key":"atypb34","unstructured":"CTFA. 1984b. Allergic contact sensitization test-night cream containing 61.3% Alcohol SD 40-B. Unpublished data submitted by CTFA (11 pages)."},{"key":"atypb35","unstructured":"CTFA. 1996. Modified Draize rabbit primary dermal irritation test. Unpublished data submitted by CTFA (5 pages)."},{"key":"atypb36","unstructured":"CTFA. 1998. Two HRIPT's of products Containing SD Alcohol 40. Unpublished data submitted by CTFA (2 pages)."},{"key":"atypb37","unstructured":"CTFA. 1999a. Phototoxicity studies of sunscreen products containing SD Alcohol 40 denatured with Brucine Sulfate. Unpublished data submitted by CTFA (5 pages)."},{"key":"atypb38","unstructured":"CTFA. 1999b. Photoallergy studies of sunscreen products containing SD Alcohol 40 denatured with Brucine Sulfate. Unpublished data submitted by CTFA (5 pages)."},{"key":"atypb39","unstructured":"CTFA. 2000a. Phototoxicity studies of sunscreen products containing SD Alcohol 40 denatured with Brucine Sulfate. Unpublished data submitted by CTFA (5 pages)."},{"key":"atypb40","unstructured":"CTFA. 2000b. Phototoxicity studies of sunscreen products containing SD Alcohol 40 denatured with Brucine Sulfate. Unpublished data submitted by CTFA (5 pages)."},{"key":"atypb41","unstructured":"CTFA. 2000c. Photoallergy studies of sunscreen products containing SD Alcohol 40 denatured with Brucine Sulfate. Unpublished data submitted by CTFA (5 pages)."},{"key":"atypb42","unstructured":"CTFA. 2000d. Photoallergy studies of sunscreen products containing SD Alcohol 40 denatured with Brucine Sulfate. Unpublished data submitted by CTFA (5 pages)."},{"key":"atypb43","unstructured":"CTFA. 2003. Concentration of use of denatured alcohol in cosmetic products, with denaturant types identified, where available. Unpublished data submitted by CTFA."},{"key":"atypb44","unstructured":"CTFA. 2005. Lidocaine data to support the safety of the lidocaine derivative Denatonium Benzoate. Unpublished data submitted by CTFA (7 pages)."},{"key":"atypb45","first-page":"244","volume":"57","year":"1995","journal-title":"Biosci. Biotech. Biochem."},{"key":"atypb46","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)96815-8"},{"key":"atypb47","first-page":"229","volume":"5","year":"1983","journal-title":"Neurobehav. Toxicol. Teratol."},{"key":"atypb48","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6793-6-8"},{"key":"atypb49","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/3.3.207"},{"key":"atypb50","doi-asserted-by":"publisher","DOI":"10.3109\/10915818509078674"},{"key":"atypb51","unstructured":"Equistar Chemicals, LP. 2004. Alcohol Product Specification SDA 40B 200 Proof. 2620-0804. Unpublished data submitted by CTFA (1 page)."},{"key":"atypb52","unstructured":"European Commission. 1999. The rules of governing cosmetic products in the European Union. Volume 1. Cosmetic legislation-Cosmetic products. http:\/\/dg3.eudra.org\/F3\/cosmetic\/pdf\/vol 1en.pdf (accessed March 26, 2003, April 2, 2004, and June 21, 2005)."},{"key":"atypb53","unstructured":"Fisher Scientific. 2003. Material safety data sheet for ethyl alcohol, denatured. http:\/\/www.atmos.umd.edu\/russ\/MSDS\/ethanol denatured.htm (accessed March 26, 2003)."},{"key":"atypb54","unstructured":"Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients.\n                      FDA Database.\n                      College Park, MD: FDA."},{"key":"atypb55","unstructured":"FDA. 2003. \u201cEverything\u201d Added to Food in the United States (EAFUS): A food additive database. http:\/\/vm.cfsan.fda.gov\/dms\/eafus.html (accessed on March 26, 2003)."},{"key":"atypb56","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0015-0282(16)40036-1","volume":"24","year":"1973","journal-title":"Fertil. Steril."},{"key":"atypb57","first-page":"357","volume":"117","year":"1984","journal-title":"Can. Pharm. J."},{"key":"atypb58","first-page":"47","volume":"44","year":"1997","journal-title":"Rev. Biol. Trop."},{"key":"atypb59","volume-title":"International cosmetic ingredient dictionary and handbook","year":"2004"},{"key":"atypb60","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-6915(82)80066-5"},{"key":"atypb61","first-page":"234","volume":"35","year":"1993","journal-title":"Vet. Hum. Toxicol."},{"key":"atypb62","unstructured":"Harrison Research Laboratories, Inc. 2001. Final Report Phototoxicity Test. Gel Formula 9804-054. Unpublished data submitted by CTFA (6 pages)."},{"key":"atypb63","unstructured":"Harrison Research Laboratories, Inc. 2002a. Final Report Repeated Insult Patch Test (RIPT). Gel Formula 9804-054. Unpublished data submitted by CTFA (14 pages)."},{"key":"atypb64","unstructured":"Harrison Research Laboratories, Inc. 2002b. Final Report Photoallergy Test. Test Material 7. Gel Formula 9804-054. Unpublished data submitted by CTFA (16 pages)."},{"key":"atypb65","unstructured":"Harrison Research Laboratories, Inc. 2003a. Final Report Repeated Insult Patch Test (RIPT). Test Material 15A. Unpublished data submitted by CTFA (11 pages)."},{"key":"atypb66","unstructured":"Harrison Research Laboratories, Inc. 2003b. Final Report Repeated Insult Patch Test (RIPT). Test Material 15B. Unpublished data submitted by CTFA (11 pages)."},{"key":"atypb67","unstructured":"Harrison Research Laboratories, Inc. 2003c. Final Report Repeated Insult Patch Test (RIPT). Test Material 14D. Unpublished data submitted by CTFA (11 pages)."},{"key":"atypb68","unstructured":"Harrison Research Laboratories, Inc. 2003d. Final Report Repeated Insult Patch Test (RIPT). Test Material 15A SCP2275. Unpublished data submitted by CTFA (11 pages)."},{"key":"atypb69","unstructured":"Harrison Research Laboratories, Inc. 2004a. Final Report Repeated Insult Patch Test. Test Material 6. Spray Liquid Formula 0086-024. Unpublished data submitted by CTFA (17 pages)."},{"key":"atypb70","unstructured":"Harrison Research Laboratories, Inc. 2004b. Final Report Phototoxicity Test. Test material 6: Spray Liquid, Formula 0086-024. Unpublished data submitted by CTFA (17 pages)."},{"key":"atypb71","unstructured":"Harrison Research Laboratories, Inc. 2004c. Final Report Photoallergy Test. Test Material 6. Spray Liquid Formula 0086-024. Unpublished data submitted by CTFA (13 pages)."},{"key":"atypb72","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(77)90190-7"},{"key":"atypb73","unstructured":"Hay, J. E. 1963. Quaternary salts as denaturants for organic substances. United States Patent Office. (8 pages.)"},{"key":"atypb74","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(84)90109-2"},{"key":"atypb75","doi-asserted-by":"publisher","DOI":"10.1016\/S0045-6535(97)10033-9"},{"key":"atypb76","doi-asserted-by":"publisher","DOI":"10.1039\/AN9679200036"},{"key":"atypb77","doi-asserted-by":"publisher","DOI":"10.1159\/000132333"},{"key":"atypb78","unstructured":"International Agency for Research on Cancer (IARC). 1988.\n                      IARC Monographs on the Evaluation of Carcinogenic Risks to Humans\n                      ,\n                      Volume 44: Alcohol Drinking\n                      , 35. Lyon: IARC."},{"key":"atypb79","unstructured":"International Research and Development Corporation. 1976. Acute Oral Toxicity Studies in Rats and Rabbits. NTIS Report No. PB81139339."},{"key":"atypb80","unstructured":"International Research and Development Corporation. 1977a. Contract for Testing the Acute and Chronic Toxicity of Denatonium Benzoate, an Acerbic Ingredient Proposed for Use in Bad-Tasting Paint to Prevent Paint Pica. One Year Oral Toxicity Study in Monkeys. Report Number 3E. NTIS Report No. PB81-139362."},{"key":"atypb81","unstructured":"International Research and Development Corporation. 1977b. Contract for Testing the Acute and Chronic Toxicity of Denatonium Benzoate, an Acerbic Ingredient Proposed for Use in Bad-Tasting Paint to Prevent Paint Pica. Two Year Oral Toxicity Study in Rats. Report Number 2E. NTIS Report No. PB81-139347."},{"key":"atypb82","unstructured":"International Research and Development Corporation. 1978. Contract for Testing the Acute and Chronic Toxicity of Denatonium Benzoate, an Acerbic Ingredient Proposed for Use in Bad-Tasting Paint to Prevent Paint Pica. Two Year Oral Toxcity Study in Rats. Report Number 2F. NTIS Report No. PB81-139354."},{"key":"atypb83","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(03)00246-8"},{"key":"atypb84","doi-asserted-by":"publisher","DOI":"10.1177\/153537020222700406"},{"key":"atypb85","first-page":"323","volume":"37","year":"1995","journal-title":"Vet. Hum. Toxicol."},{"key":"atypb86","doi-asserted-by":"publisher","DOI":"10.1300\/J251v07n03_28"},{"key":"atypb87","doi-asserted-by":"publisher","DOI":"10.1038\/302258a0"},{"key":"atypb88","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.3.578"},{"key":"atypb89","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agh248"},{"key":"atypb90","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.45.1354"},{"key":"atypb91","first-page":"44","volume":"7","year":"1999","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"atypb92","first-page":"176","volume":"23","year":"1978","journal-title":"Int. J. Fertil."},{"key":"atypb93","first-page":"545","volume":"33","year":"1991","journal-title":"Vet. Hum. Toxicol."},{"key":"atypb94","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)33334-8"},{"key":"atypb95","doi-asserted-by":"publisher","DOI":"10.1016\/0379-0738(83)90085-3"},{"key":"atypb96","doi-asserted-by":"publisher","DOI":"10.1007\/BF00990319"},{"key":"atypb97","first-page":"311","volume":"33","year":"1986","journal-title":"Pediatr. Toxicol."},{"key":"atypb98","first-page":"316","volume":"14","year":"1976","journal-title":"Indian J. Exp. Biol."},{"key":"atypb99","doi-asserted-by":"publisher","DOI":"10.1016\/0378-8741(92)90028-P"},{"key":"atypb100","first-page":"5","volume":"25","year":"1985","journal-title":"Am. Pharm."},{"key":"atypb101","doi-asserted-by":"publisher","DOI":"10.1002\/dev.420100504"},{"key":"atypb102","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/19.4.361"},{"key":"atypb103","unstructured":"Medical Chemical Corporation. 1992. Material safety data sheet for ethyl alcohol, 70%. http:\/\/www.med-chem.com\/MSDS\/175E.html (accessed on March 26, 2003)."},{"key":"atypb104","first-page":"41","volume":"16","year":"1972","journal-title":"Acta. Cytol."},{"key":"atypb105","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF01318871","volume":"25","year":"1980","journal-title":"Digest. Dis. Sci."},{"key":"atypb106","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1952.02930180084026"},{"key":"atypb107","unstructured":"Ministry of Health, Labor and Welfare (MHLW). 2001a. Unofficial translation of MHW Ordinance No. 331, Attached Table 1 [Negative list]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical safety Bureau, Inspection and Guidance Division, 2-2, 1-chome, Kasumigaseki, Chiyoda-ku, To kyo 100-8045, Japan."},{"key":"atypb108","unstructured":"MHLW. 2001b. Unofficial translation of MHW Ordinance No. 331, Attached Table 2 [Restricted list]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical safety Bureau, Inspection and Guidance Division, 2-2, 1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan."},{"key":"atypb109","unstructured":"NAMSA. 2004. Vaginal irritation study in the rabbit. Unpublished data submitted by CTFA (14 pages)."},{"key":"atypb110","unstructured":"National Library of Medicine-Medline Plus. 2005. Lidocaine drug information. www.nlm.nih.gov\/medlineplus\/druginfo\/uspdi\/500058.html (accessed March 30, 2005)."},{"key":"atypb111","unstructured":"National Toxicology Program (NTP). 1985. Ethanol: Reproduction and fertility assessment in CD-1 mice when administered in the drinking water. NTIS Report No. PB86144979."},{"key":"atypb112","unstructured":"NTP. 2004. Genetic Toxicology. Data on Brucine. http:\/\/ntp.niehs.nih.gov (accessed on October 15, 2004)."},{"key":"atypb113","doi-asserted-by":"publisher","DOI":"10.1177\/074823379000600302"},{"key":"atypb114","doi-asserted-by":"publisher","DOI":"10.1179\/oeh.2000.6.2.143"},{"key":"atypb115","first-page":"67","volume":"2","year":"1973","journal-title":"Fo r ensic Sci."},{"key":"atypb116","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-958044"},{"key":"atypb117","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1218(79)90160-5"},{"key":"atypb118","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1110(79)90004-6"},{"key":"atypb119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2004.00280.x"},{"key":"atypb120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1996.tb02393.x"},{"key":"atypb121","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)00672-3"},{"key":"atypb122","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.35.3082"},{"key":"atypb123","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1997.8161"},{"key":"atypb124","first-page":"859","volume":"151","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"key":"atypb125","first-page":"30","volume":"144","year":"1989","journal-title":"Drug Cosmet. Ind."},{"key":"atypb126","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-6915(00)00120-4"},{"key":"atypb127","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/16.2.91"},{"key":"atypb128","doi-asserted-by":"publisher","DOI":"10.1081\/DCT-120022648"},{"key":"atypb129","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)00615-2"},{"key":"atypb130","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(92)90087-I"},{"key":"atypb131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1990.tb01830.x"},{"key":"atypb132","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(94)00165-2"},{"key":"atypb133","doi-asserted-by":"publisher","DOI":"10.1007\/s002040100242"},{"key":"atypb134","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1975.tb09513.x"},{"key":"atypb135","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(84)90316-6"},{"key":"atypb136","first-page":"105","volume":"3","year":"1981","journal-title":"Neurobehav. Toxicol. Teratol."},{"key":"atypb137","unstructured":"Rossoff, I. S.1974.Handbook of veterinary drugs, 53. New York: Springer Publishing Company."},{"key":"atypb138","doi-asserted-by":"publisher","DOI":"10.3758\/BF03326648"},{"key":"atypb139","unstructured":"Schaefer, H., and T. E. Redelmeier. 1996.Skin barrier: Principles of percutaneous absorption, 247. Basal: Kargar."},{"key":"atypb140","first-page":"630","volume":"142","year":"1988","journal-title":"Am. J. D. S. Child"},{"key":"atypb141","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12723090"},{"key":"atypb142","first-page":"921","volume":"96","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"atypb143","first-page":"501","volume":"58","year":"1970","journal-title":"Indian J. Med. Res."},{"key":"atypb144","first-page":"25","volume":"10","year":"1978","journal-title":"J. Drug Res. Egypt"},{"key":"atypb145","doi-asserted-by":"publisher","DOI":"10.1021\/jo000877g"},{"key":"atypb146","doi-asserted-by":"publisher","DOI":"10.1136\/emj.8.1.1"},{"key":"atypb147","first-page":"191","volume":"245","year":"1995","journal-title":"Mutat. Res."},{"key":"atypb148","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-959661"},{"key":"atypb149","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600620119"},{"key":"atypb150","first-page":"1138","volume":"35","year":"1990","journal-title":"J. Fo r ensic Sci."},{"key":"atypb151","first-page":"108","volume":"21","year":"1983","journal-title":"Indian J. Exp. Biol."},{"key":"atypb152","doi-asserted-by":"publisher","DOI":"10.1139\/v91-125"},{"key":"atypb153","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1980.03310180015010"},{"key":"atypb154","doi-asserted-by":"publisher","DOI":"10.1126\/science.6992275"},{"key":"atypb155","unstructured":"Syracuse Research Corp. 2005. Log P calculations for Brucine, Quassin, and Denatonium Benzoate. www.syrres.com\/esc\/kowwin.htm (accessed February 28, 2005)."},{"key":"atypb156","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4020(01)96295-7"},{"key":"atypb157","unstructured":"Union Carbide Corporation. 2000. Material Safety Data Sheet. Unpublished data submitted by CTFA. (14 pages)."},{"key":"atypb158","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(00)00120-2"},{"key":"atypb159","first-page":"930","volume":"132","year":"1978","journal-title":"Am. J. Dis. Child"},{"key":"atypb160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050265"},{"key":"atypb161","doi-asserted-by":"publisher","DOI":"10.2131\/jts.8.243"},{"key":"atypb162","doi-asserted-by":"crossref","unstructured":"Watson, W. A., T. L. Litovitz, G. C. Rodgers, W. Klein-Schwartz, N. Reid, J. Youniss, A. Flanagan, and K. M. Wruk. 2005. 2004 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. http:\/\/www.poison.org\/prevent\/documents\/TESS%Annual% 20Report%202004.pdf.","DOI":"10.1016\/j.ajem.2005.05.001"},{"key":"atypb163","first-page":"227","volume":"2","year":"1980","journal-title":"Neurobehav. Toxicol."},{"key":"atypb164","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(70)90077-3"},{"key":"atypb165","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-003-1852-y"}],"container-title":["International Journal of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/10915810802032388","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/10915810802032388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:22:48Z","timestamp":1777458168000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/10915810802032388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":165,"journal-issue":{"issue":"1_suppl","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1080\/10915810802032388"],"URL":"https:\/\/doi.org\/10.1080\/10915810802032388","relation":{},"ISSN":["1091-5818","1092-874X"],"issn-type":[{"value":"1091-5818","type":"print"},{"value":"1092-874X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}